How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance director
[Adobe Stock] In the U.S. market, generics play a significant role in reducing overall drug spending. The FDA, for instance, estimated that the generics it approved in 2022 alone saved $18.9 billion in their first year on the market. Those savings come out …